Sponsored Links

Teva Announces Launch Of Generic Aricept(R) Tablets In The United States PDF Print E-mail
Medical News - Alzheimer's and Dementia
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of Eisai's Alzheimer's treatment AriceptĀ® (Donepezil Hydrochloride) Tablets, 5 mg and 10 mg. Shipment of this product has commenced...

Read more: Alzheimer's / Dementia News From Medical News Today